Valneva SE (VALN) Other Operating Expenses (2021 - 2026)
Valneva SE (VALN) posted Other Operating Expenses of $2.3 million for Q1 2026, down 18.27% sequentially from $2.8 million in Q4 2025, and little changed YoY from $2.3 million in Q1 2025.
Valneva SE (VALN) Other Operating Expenses (2021 - 2026) Analysis & Trends
Valneva SE has reported Other Operating Expenses for 6 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Other Operating Expenses changed 0.35% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (down 45.29% YoY) and the FY2025 annual result came in at $12.1 million, down 45.98% from the prior year.
- Other Operating Expenses eased to $2.3 million in Q1 2026 per VALN's latest filing, from $2.8 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $11.5 million in Q2 2023 and troughed at $1.6 million in Q2 2022.
- A 5-year average of $4.3 million and a median of $3.7 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 81.91% in 2022, then surged 610.03% in 2023.
- Over 5 years, Other Operating Expenses stood at $4.8 million in 2022, then grew by 0.39% to $4.8 million in 2023, then grew by 28.36% to $6.2 million in 2024, then slumped by 55.42% to $2.8 million in 2025, then dropped by 18.27% to $2.3 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $2.3 million, $2.8 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 9.37 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 11.46 Mn |
| Mar 31, 2023 | 3.74 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 6.66 Mn |